Home
Resources
Publications
Involvement of Src Kinases and PLCgamma2 in Clot Retraction

Involvement of Src Kinases and PLCgamma2 in Clot Retraction

Katsue Suzuki-Inoue, Craig E Hughes, Osamu Inoue, Makoto Kaneko, Olga Cuyun-Lira, Toshiro Takafuta, Steve P Watson, Yukio Ozaki

Thromb Res. 2007;120(2):251-8.

PMID: 17055557

Abstract:

The integrin alpha(IIb)beta(3) plays a critical role in mediating clot retraction by platelets which is important in vivo in consolidating thrombus formation. Actin-myosin interaction is essential for clot retraction. In the present study, we demonstrate that the structurally distinct Src kinase inhibitors, PP2 and PD173952, significantly reduced the rate of clot retraction, but did not prevent it reaching completion. This effect was accompanied by abolition of alpha(IIb)beta(3)-dependent protein tyrosine phosphorylation, including PLCgamma2. A role for PLCgamma2 in mediating clot retraction was demonstrated using PLCgamma2-deficient murine platelets. Furthermore, platelet adhesion to fibrinogen leads to MLC phosphorylation through a pathway that is inhibited by PP2 and by the PLC inhibitor, U73122. These results demonstrate a partial role for Src kinase-dependent activation of PLCgamma2 and MLC phosphorylation in mediating clot retraction downstream of integrin alpha(IIb)beta(3).

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP305820751	PD173952		305820-75-1	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: